Michael D Loberg - Net Worth and Insider Trading

Michael D Loberg Net Worth

The estimated net worth of Michael D Loberg is at least $3 Million dollars as of 2024-03-28. Michael D Loberg is the Director of Arqule Inc and owns about 132,142 shares of Arqule Inc (ARQL) stock worth over $3 Million. Michael D Loberg is also the Director of IGM Biosciences Inc and owns about 72,627 shares of IGM Biosciences Inc (IGMS) stock worth over $700,851. Details can be seen in Michael D Loberg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael D Loberg has not made any transactions after 2022-09-28 and currently still holds the listed stock(s).

Transaction Summary of Michael D Loberg

To

Michael D Loberg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael D Loberg owns 3 companies in total, including IGM Biosciences Inc () , Arqule Inc () , and AMAG Pharmaceuticals Inc () .

Click here to see the complete history of Michael D Loberg’s form 4 insider trades.

Insider Ownership Summary of Michael D Loberg

Ticker Comapny Transaction Date Type of Owner
IGM Biosciences Inc 2022-09-28 director
Arqule Inc 2020-01-16 director
AMAG Pharmaceuticals Inc 2008-12-19 director

Michael D Loberg Latest Holdings Summary

Michael D Loberg currently owns a total of 2 stocks. Among these stocks, Michael D Loberg owns 132,142 shares of Arqule Inc (ARQL) as of December 17, 2015, with a value of $3 Million and a weighting of 79.04%. Michael D Loberg also owns 72,627 shares of IGM Biosciences Inc (IGMS) as of September 28, 2022, with a value of $700,851 and a weighting of 20.96%.

Latest Holdings of Michael D Loberg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARQL Arqule Inc 2015-12-17 132,142 20.00 2,642,840
IGMS IGM Biosciences Inc 2022-09-28 72,627 9.65 700,851

Holding Weightings of Michael D Loberg


Michael D Loberg Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael D Loberg has made a total of 0 transactions in Arqule Inc (ARQL) over the past 5 years. The most-recent trade in Arqule Inc is the acquisition of 3,719 shares on December 17, 2015, which cost Michael D Loberg around $8,033.

According to the SEC Form 4 filings, Michael D Loberg has made a total of 3 transactions in IGM Biosciences Inc (IGMS) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in IGM Biosciences Inc is the acquisition of 6,679 shares on September 28, 2022, which cost Michael D Loberg around $139,524.

Insider Trading History of Michael D Loberg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael D Loberg Trading Performance

GuruFocus tracks the stock performance after each of Michael D Loberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael D Loberg is -9.21%. GuruFocus also compares Michael D Loberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael D Loberg within 3 months outperforms 15 times out of 44 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael D Loberg's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael D Loberg

Average Relative Return

-0.35%

Average relative return per transaction

Outperforming Transactions

41%

18 out of 44 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -1.8 -9.21 -9.81 -0.35 3.09 8.29
Relative Return to S&P 500(%) -0.6 -4.85 -3.3 6.68 0.45 4.03

Michael D Loberg Ownership Network

Ownership Network List of Michael D Loberg

No Data

Ownership Network Relation of Michael D Loberg


Michael D Loberg Owned Company Details

What does IGM Biosciences Inc do?

Who are the key executives at IGM Biosciences Inc?

Michael D Loberg is the director of IGM Biosciences Inc. Other key executives at IGM Biosciences Inc include Principal Accounting Officer Steven Weber , Chief Medical Officer Chris H Takimoto , and Chief Financial Officer Misbah Tahir .

IGM Biosciences Inc () Insider Trades Summary

Over the past 18 months, Michael D Loberg made no insider transaction in IGM Biosciences Inc (). Other recent insider transactions involving IGM Biosciences Inc () include a net sale of 45,975 shares made by Bruce Keyt , a net sale of 11,918 shares made by George Gauthier , and a net sale of 14,987 shares made by Lisa Lynn Decker .

In summary, during the past 3 months, insiders sold 28,125 shares of IGM Biosciences Inc () in total and bought 0 shares, with a net sale of 28,125 shares. During the past 18 months, 229,745 shares of IGM Biosciences Inc () were sold and 795,616 shares were bought by its insiders, resulting in a net purchase of 565,871 shares.

IGM Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

IGM Biosciences Inc Insider Transactions

No Available Data

Michael D Loberg Mailing Address

Above is the net worth, insider trading, and ownership report for Michael D Loberg. You might contact Michael D Loberg via mailing address: C/o Arqule, Inc., 1 Wall Street, 6th Floor, Burlington Ma 01803.

Discussions on Michael D Loberg

No discussions yet.